Upload File

powerpoint presentation - asgct...leukapheresis apheresis material obtained from patient via...

  • Home
  • Documents
  • PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
11

Upload: others

Post on 06-Jun-2020

7 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 2: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 3: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 4: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 5: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 6: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 7: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 8: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 9: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 10: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,
Page 11: PowerPoint Presentation - ASGCT...Leukapheresis Apheresis material obtained from patient via standard leukapheresis collection Celgene PBMC Isolation PBMCs isolated Cell Activation,

Report on a Collaborative study for Proposed 2 nd ... · haematopoietic progenitor cells into the peripheral blood for collection by leukapheresis and haematopoietic stem-cell transplantation

This presentation contains forward-looking statements. All ...uniqure.com/ASGCT 2019 - AMT-130 Minipig Data Presentation.pdf · Assessment of AMT-130 persistence in a large brain

Vergleichende Untersuchung der Zellapoptose mononukleärer ... · cantly higher in leukapheresis products than in the LRS chambers. In both leukocyte In both leukocyte products a

Transcriptomic Analysis of PBMCs from Allergic Patients ...epubs.surrey.ac.uk/842012/1/Transcriptomic profile in patients with... · Austin Journal of Nutrition & Metabolism. Open

SOP.1. Diagnostic LeukApheresis - Universiteit Twente · 2020. 10. 30. · COBE Spectra™ Apheresis System manual MNC Collection Procedure: Program the apheresis device for mononuclear

PBMC Isolation from Leukapheresis

Diagnostic Leukapheresis Enables Reliable Transcriptomic ... · cancers Article Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells

Senators Tim Scott and Cory Booker - ASGCT › ASGCT › media › about › Final-Presentations-… · globin production 3. Gene editing based cell therapy3 2. HSC gene addition

8°Congreso Argentino de Infectología Pediátrica. Abril ...a/Lunes 24/Dra... · 14.3 años HIV DNA (copies/million PBMCs)

ASGCT Translational Sciences Training Course Design of ... · ribozyme, microRNA, hairpin, decoys etc) Recent arguments against labeling ODNs as gene therapy Unable to integrate into

Collecting Blood and Isolating PBMCs

Clinical Development and Manufacture of Chimeric …...critical step, harvesting via leukapheresis, to reinfusion, as well as reviewing the clinical evidence in support of the use

BY: SHAN AND BITA. Background: MIF= cytokine macrophage migration inhibitory factor gp120= HIV-1 envelop glycoprotein p24= HIV-1 antigen PBMCS= peripheral

EXHIBITOR AND SUPPORTER PROSPECTUS - … · many branding and contact opportunities available only through ASGCT. ... The closing night reception has quickly become the social highlight

INNOVATOR INSIGHT The Importance of Collection, Processing …€¦ · cess, since the number of healthy cells in leukapheresis-derived starting material directly impacts the efficacy

ASGCT and FDA Liaison Meeting

therapy. with rheumatoid arthritis by leukapheresis€¦ · repeated leukapheresis procedures that removed all circulating monocytes. Highly enriched monocyte preparations from the

American Society of Gene & Cell Therapy | ASGCT - FDA’s … · 2020. 9. 9. · Suite of Gene Therapy Draft Guidance Documents –July 2018 1. Chemistry, Manufacturing, and Control

Best Practices for PBMC Processing from Leukapheresis ... · Cryopreservation Solution (CPS) ... with a manual cell count . ... • ACTG requires temporary onsite storage in a -70/-80°C

PBMC Isolation from Leukapheresis La… · 61-PBMCIsolationFromLeukapheresis-LTC-SOP-v1.0-2013-06-11 Page 1 of 35 PBMC Isolation from Leukapheresis ... Users of the ACTG/IMPAACT Lab

Gene Editing Workshop - ASGCT...discovery, small molecule drug repositioning, and protein engineering . Previously, as vice president of discovery at Eleven Biotherapeutics, Tom led

Commercialization Workshop - ASGCT · in human stem cell biology and developed a series of life science ... transactions including partnering Syros’ technology platform and drug

Intracellular Cytokine Staining on PBMCs Using CyTOF … · Vol 5, Iss 1, Jan 05, 2015 . Intracellular Cytokine Staining on PBMCs Using CyTOF. TM. Mass Cytometry

Timeline Slides PDF Version - ASGCT

RODRIGO BARBANO WEINGRILL EXPRESSÃO DA … · significativa do potencial migratório das PBMCs (7 ± 1,63) comparado ao controle (ODN scramble, 13 ± 2,16). Resultados similares

Development and Optimization of a GMP Compliant ...€¦ · Lysate Dendritic Cell Vaccine ... (CER‐VD 426/15, 2015). The collection and transportation of tumor samples and leukapheresis

Leukapheresis* by Continuous Flow Centrifugation (CFC) in - Blood

Curing HIV: Coping with Hope - PAETCpaetc.org/wp-content/uploads/2014/06/Coping2014.Mitsuyasu.ARS_.… · Autologous ZFN CCR5-Disrupted CD4+ T-cells Leukapheresis Enriched CD4+ Adenoviral

Dendritic cells in cancer immunotherapy · 2019. 10. 25. · Dendritic Cell Based Vaccines in Cancer Treatment . Vaccination . Antigen-Pulsed DC (systemic) Leukapheresis DC Generation

Phase-Appropriate Viral Clearance Strategy for Sf9 ......ASGCT -2020Annual Meeting I May 12 –15, 2020I VirtualPhase-Appropriate Viral Clearance Strategy for Sf9/BaculovirusBased

Cytokine-Induced Killer Cells as an Adoptive Cellular ...article.biochemmolbio.org/pdf/10.11648.j.bmb.20190401.12.pdf · human peripheral blood mononuclear cells (PBMCs) and measures

Towards AAV5-mediated Gene Therapy for Hemophilia A with a ... ASGCT - Hemophilia A Presentation.pdf · This presentation contains forward-looking statements. All statements other

ChangesintheTh1:Th2CytokineBiasinPregnancyandthe …downloads.hindawi.com/journals/mi/2012/416739.pdf ·  · 2014-03-26Peripheral blood mononuclear cells (PBMCs) from women at 28

Clinically Meaningful Endpoints ASGCT 201717

Characterizing Cardiovascular Outcomes Associated with … · 2020. 7. 22. · 1)Leukapheresis: T cells are extracted from the patient’s blood. 2)Cells are transduced to express